
Allied Healthcare Products AHPI
Annual report 2022
added 10-07-2022
Allied Healthcare Products DSO Ratio 2011-2026 | AHPI
Annual DSO Ratio Allied Healthcare Products
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 161 | 162 | 103 | 37 | 40.7 | 36.8 | 41.7 | 36.9 | 37.4 | 40.3 | 41.1 | 42.6 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 162 | 36.8 | 65 |
Quarterly DSO Ratio Allied Healthcare Products
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | 33.3 | 36.8 | 37.4 | 39.5 | 39.2 | 28.7 | 28.6 | 27.7 | 37 | 38.1 | 36.3 | 39.5 | 37.6 | 37.3 | 43.6 | 42.2 | 39.5 | 36.7 | 39.3 | 18.5 | 35.2 | 35.8 | 39.5 | 45.2 | 42.2 | 37.5 | 38.4 | 36.9 | 36.9 | 34.7 | 37.6 | 37.6 | 37.2 | 37.1 | 41.1 | 44 | 40.7 | 33.4 K | 42.6 K | 45.1 | 44.5 | 40 | 42.1 | 45.9 | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 42.6 K | 18.5 | 1.76 K |
DSO Ratio of other stocks in the Medical devices industry
| Issuer | DSO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Alphatec Holdings
ATEC
|
43.1 | $ 11.1 | 1.83 % | $ 1.67 B | ||
|
Cytosorbents Corporation
CTSO
|
73.2 | $ 0.58 | -5.66 % | $ 36.1 M | ||
|
AxoGen
AXGN
|
40.7 | $ 32.07 | 0.34 % | $ 1.48 B | ||
|
EDAP TMS S.A.
EDAP
|
91.8 | $ 3.32 | 0.61 % | $ 124 M | ||
|
GenMark Diagnostics, Inc.
GNMK
|
44.2 | - | - | $ 1.77 B | ||
|
Helius Medical Technologies
HSDT
|
53.3 | $ 1.9 | 0.53 % | $ 1.15 M | ||
|
Acutus Medical
AFIB
|
746 | - | -26.83 % | $ 2.62 M | ||
|
Align Technology
ALGN
|
86.7 | $ 176.99 | 2.22 % | $ 13.3 B | ||
|
AdaptHealth Corp.
AHCO
|
43.8 | $ 12.16 | -0.08 % | $ 1.64 B | ||
|
Lianluo Smart Limited
LLIT
|
215 | - | 24.59 % | $ 44.8 M | ||
|
IRIDEX Corporation
IRIX
|
47.5 | $ 1.0 | 0.31 % | $ 16.9 M | ||
|
Axonics Modulation Technologies
AXNX
|
49.2 | - | - | $ 3.31 B | ||
|
Obalon Therapeutics, Inc.
OBLN
|
724 | - | -5.86 % | $ 30.6 M | ||
|
Bio-Rad Laboratories
BIO
|
66.9 | $ 285.12 | 2.1 % | $ 8.04 B | ||
|
BioSig Technologies
BSGM
|
607 | - | 37.08 % | $ 85.7 M | ||
|
Conformis
CFMS
|
55.4 | - | - | $ 16.4 M | ||
|
Bruker Corporation
BRKR
|
57.3 | $ 38.56 | 2.58 % | $ 5.74 K | ||
|
Boston Scientific Corporation
BSX
|
65.7 | $ 62.21 | 0.68 % | $ 92.1 B | ||
|
LivaNova PLC
LIVN
|
53.8 | $ 63.07 | 0.46 % | $ 3.44 B | ||
|
LENSAR
LNSR
|
38.9 | $ 5.81 | 1.93 % | $ 69.5 M | ||
|
Apollo Endosurgery
APEN
|
59.5 | - | - | $ 475 M | ||
|
Cardiovascular Systems
CSII
|
61.6 | - | 0.15 % | $ 844 M | ||
|
ClearPoint Neuro
CLPT
|
55.6 | $ 9.48 | 9.16 % | $ 268 M | ||
|
Dynatronics Corporation
DYNT
|
41.6 | - | 14.99 % | $ 929 K | ||
|
Electromed
ELMD
|
137 | $ 24.38 | 1.08 % | $ 206 M | ||
|
CryoLife, Inc.
CRY
|
70.3 | - | -4.14 % | $ 702 M | ||
|
Avinger
AVGR
|
49.4 | - | -20.74 % | $ 369 K | ||
|
Second Sight Medical Products
EYES
|
49.1 | - | -0.97 % | $ 54.4 M | ||
|
Inogen
INGN
|
35.8 | $ 6.53 | 3.08 % | $ 174 M | ||
|
CHF Solutions, Inc.
CHFS
|
52.9 | - | 1.15 % | $ 34.5 M | ||
|
Aziyo Biologics
AZYO
|
59.5 | - | 1.37 % | $ 20.5 M | ||
|
Hancock Jaffe Laboratories, Inc.
HJLI
|
62.7 | - | -1.98 % | $ 98.3 M | ||
|
GBS
GBS
|
61.2 | - | -0.57 % | $ 7.12 M | ||
|
Itamar Medical Ltd.
ITMR
|
85.4 | - | 0.03 % | $ 1.58 B | ||
|
Misonix, Inc.
MSON
|
64.6 | - | - | $ 462 M | ||
|
Neovasc
NVCN
|
120 | - | - | $ 111 M | ||
|
OrthoPediatrics Corp.
KIDS
|
74.3 | $ 16.59 | 3.88 % | $ 389 M | ||
|
Globus Medical
GMED
|
76.8 | $ 92.02 | 1.77 % | $ 12.4 B | ||
|
Sintx Technologies
SINT
|
67 | $ 2.83 | 5.6 % | $ 7.85 M | ||
|
Butterfly Network
BFLY
|
76.1 | $ 4.12 | 0.12 % | $ 872 M | ||
|
Intersect ENT, Inc.
XENT
|
66.1 | - | - | $ 955 M | ||
|
BIOLASE
BIOL
|
42 | - | -13.19 % | $ 166 K | ||
|
Stryker Corporation
SYK
|
204 | $ 341.63 | 0.73 % | $ 131 B | ||
|
Delcath Systems
DCTH
|
48.5 | $ 10.22 | 1.79 % | $ 366 M | ||
|
Myomo
MYO
|
35.3 | $ 0.7 | 0.93 % | $ 29.3 M | ||
|
TELA Bio
TELA
|
46.5 | $ 0.56 | -0.78 % | $ 26.3 M | ||
|
Inspire Medical Systems
INSP
|
42.6 | $ 54.05 | 0.06 % | $ 1.59 B | ||
|
CONMED Corporation
CNMD
|
64.5 | $ 37.4 | 1.8 % | $ 1.16 B |